Table 1.
Clinical and demographic data of acute flaccid paralytic patients with CV-B infection characterized in this study
| Serotype identified in this study | Isolate ID | Sex |
Age
(months) |
Fever | Asymmetric paralysis | Progression |
|---|---|---|---|---|---|---|
| CV-B1 | PAK-MEV3757B | F | 30 | Yes | Yes | Yes |
| CV-B1 | PAK-MEV3688B | M | 86 | No | Yes | Yes |
| CV-B1 | PAK-MEV5726A | M | 21 | Yes | Yes | Yes |
| CV-B2 | PAK-MEV2058A | F | 24 | Yes | Yes | Yes |
| CV-B3 | PAK-MEV1452A | F | 36 | Yes | Yes | Yes |
| CV-B3 | PAK-MEV4565A | M | 24 | Yes | Yes | Yes |
| CV-B4 | PAK-MEV076B | M | 36 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV1620B | M | 4 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV1177A | M | 16 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV467B | M | 18 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV5777A | F | 36 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV5959A | M | 36 | No | Yes | Yes |
| CV-B5 | PAK-MEV3586B | F | 23 | No | Yes | Yes |
| CV-B5 | PAK-MEV5926A | M | 49 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV3271A | M | 4 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV5959A | M | 36 | No | Yes | Yes |
| CV-B5 | PAK-MEV2005B | M | 23 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV3903A | F | 72 | Yes | Yes | Yes |
| CV-B5 | PAK-MEV5810B | M | 36 | Yes | Yes | Yes |
| CV-B6 | PAK-MEV674B | F | 18 | Yes | Yes | Yes |
| CV-B6 | PAK-MEV2475A | M | 24 | Yes | Yes | Yes |
| CV-B6 | PAK-MEV4600A | F | 18 | Yes | Yes | yes |
| CV-B6 | PAK-MEV627A | M | 18 | Yes | Yes | Yes |
| CV-B6 | PAK-MEV4553A | F | 36 | Yes | Yes | Yes |
M, male; F, female; CV, coxsackievirus.